ANRO (Alto Neuroscience) 3-Year EBITDA Growth Rate : -38.20% (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience 3-Year EBITDA Growth Rate?

Alto Neuroscience's EBITDA per Share for the three months ended in Dec. 2024 was $-0.55.

During the past 3 years, the average EBITDA Per Share Growth Rate was -38.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 4 years, the highest 3-Year average EBITDA Per Share Growth Rate of Alto Neuroscience was -38.20% per year. The lowest was -38.20% per year. And the median was -38.20% per year.

Competitive Comparison of Alto Neuroscience's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Alto Neuroscience's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alto Neuroscience's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alto Neuroscience's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Alto Neuroscience's 3-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Alto Neuroscience 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Alto Neuroscience (NYSE:ANRO) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Alto Neuroscience 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Alto Neuroscience's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Alto Neuroscience Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

650 Castro Street, Suite 450, Mountain View, CA, USA, 94041

Website

https://www.altoneuroscience.com

Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.